67 reports

Cystic Fibrosis (CF) - Epidemiology Forecast to 2030 Summary Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems.In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct...

  • Cystic Fibrosis
  • Epidemiology
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • Spain
  • World
  • France
  • Italy
  • United States
  • Cause-Specific Mortality Rate
  • Prescription Drug Sales

“Cystic Fibrosis - Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Cystic Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Cystic Fibrosis
  • World

Abstract: - Global Cystic Fibrosis Devices Market to Reach $954.2 Million by 2027 - Amid the COVID-19 crisis, the global market for Cystic Fibrosis Devices estimated at US$532.6 Million in the year 2020, is projected to reach a revised size of US$954.2 Million by 2027, growing at a CAGR of 8.7% over the period 2020-2027....

  • Cystic Fibrosis
  • World
  • China
  • United States

Abstract: - Global Cystic Fibrosis \Therapeutics Market to Reach $13.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cystic Fibrosis \Therapeutics estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$13.2 Billion by 2027, growing at a CAGR of 12.2% over the analysis...

  • Cystic Fibrosis
  • World
  • China
  • United States

Abstract: - Global Cystic Fibrosis \Therapeutics Market to Reach $13.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cystic Fibrosis \Therapeutics estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$13.2 Billion by 2027, growing at a CAGR of 12.2% over the analysis...

  • Cystic Fibrosis
  • World
  • China
  • United States

Cystic Fibrosis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2021, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited...

  • Cystic Fibrosis
  • World
  • Europe

Cystic Fibrosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2020, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that...

  • Cystic Fibrosis
  • Europe
  • World

Cystic Fibrosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H1 2020, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that...

  • Cystic Fibrosis
  • Europe
  • World

The global cystic fibrosis therapeutics market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...

  • Cystic Fibrosis
  • World
  • Health Expenditure

KEY FINDINGS The global cystic fibrosis therapeutics market is anticipated to grow at a rate of 10.04% during the estimated period of 2020-2028. A rise in incidences of cystic fibrosis across the globe, an increase in medications against cystic fibrosis, and a hike in R&D investments towards the development of drugs to...

  • Cystic Fibrosis
  • World
  • Europe

Cystic Fibrosis (CF) Therapeutics Market Report Overview Cystic Fibrosis (CF) Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cystic Fibrosis (CF) Therapeutics market types and applications. It is a focused study on Cystic...

  • Therapy
  • Cystic Fibrosis
  • World
  • Health Provider Density

Cystic Fibrosis (CF) Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Cystic Fibrosis (CF) Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Cystic Fibrosis (CF) Therapeutics...

  • Therapy
  • Cystic Fibrosis
  • World

“Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026” Report Highlights: • Global CFTR Modulators Market Opportunity: > US$ 20 Billion • Global CFTR Modulators Market Growth: 42% CAGR (2017 -2020) • Global CFTR Modulators Market Growth In 2020: 55% • Global CFTR Modulators...

  • Cystic Fibrosis
  • Clinical Trial
  • World

Airway Clearance System Market by type (Positive Expiratory Pressure, High Frequency Chest Wall Oscillation, Oscillating PEP devices, Intrapulmonary Percussive Ventilators and Mechanical Cough Assist), Application (Emphysema, Cystic fibrosis, Neuromuscular Bronchiectasis and End-User (Hospital & Clinics, Ambulatory Surgical Centers,...

  • Respiratory Disease
  • Cystic Fibrosis
  • Healthcare
  • World
  • APAC
  • Europe
  • Health Expenditure

Cystic Fibrosis (CF) Therapeutics Market by Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, and CFTR Modulators) and Route of Administration (Oral and Inhaled): Global Opportunity Analysis and Industry Forecast, 2019-2026 The global cystic fibrosis therapeutics market was valued at $4,615.4...

  • Cystic Fibrosis
  • World
  • APAC
  • Europe

KEY FINDINGS The global airway clearance system market is anticipated to record a CAGR of 4.39% over the projected period of 2019-2028. The factors boosting global market growth are the surging prevalence of cystic fibrosis and coronavirus disease, a rise in government initiatives, and growth opportunities in developing...

  • Respiratory Disease
  • Cystic Fibrosis
  • World
  • APAC

Histamine H4 Receptor - Pipeline Review, H2 2020 Summary According to the recently published report ’Histamine H4 Receptor - Pipeline Review, H2 2020’; Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) pipeline Target constitutes...

  • Dermatological Condition
  • Eye Disease
  • Ophthalmology
  • Cystic Fibrosis
  • World
  • Surgical Procedures Performed
  • Drug Approval

The Global Airway Clearance System Market size is expected to reach $774.7 Million by 2025, rising at a market growth of 4.62% CAGR during the forecast period. Airway clearance comprises of various types of treatment that help people suffering from diseases like cystic fibrosis maintain a healthy lifestyle. ACTs (Airway Clearance Techniques)...

  • Respiratory Disease
  • Respiratory Device
  • Cystic Fibrosis
  • Home Healthcare
  • World
  • Health Expenditure

Histamine H4 Receptor - Pipeline Review, H1 2020 Summary Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) pipeline Target constitutes close to 7 molecules. The latest report Histamine H4 Receptor - Pipeline Review, H1 2020, outlays...

  • Dermatological Condition
  • Pharmaceutical
  • Ophthalmology
  • Cystic Fibrosis
  • Ophthalmic Solution
  • Eye Disease
  • World
  • Surgical Procedures Performed
  • Pharmaceutical Registrations

The global newborn screening market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 9% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Healthcare
  • Diagnostics
  • Health Services
  • Cystic Fibrosis
  • Blood Disease
  • Ear Disease
  • Molecular Diagnostics
  • Endocrine Disease
  • Ear, Nose, And Throat Medicine
  • World

“Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) development. The report provides detailed coverage of the pipeline landscape...

  • Cystic Fibrosis
  • World

KEY FINDINGS The cystic fibrosis therapeutics market of Europe is anticipated to register a CAGR of 10.10% over the projected period of 2020-2028. Europe has the largest market share in the global market in terms of revenue. A rise in the incidence of cystic fibrosis has given rise to the need for newer and advanced therapeutics...

  • Healthcare
  • Cystic Fibrosis
  • Europe
  • Poland
  • Russia
  • Health Expenditure

KEY FINDINGS The cystic fibrosis therapeutics market of Asia Pacific is estimated to record a CAGR of 9.58% during the projected period of 2020-2028.The rising research and development activities in terms of novel cystic fibrosis therapeutics are anticipated to create lucrative opportunities in the future. MARKET...

  • Cystic Fibrosis
  • APAC
  • Health Expenditure

KEY FINDINGS The North America cystic fibrosis therapeutics market is estimated to register a CAGR of 10.07% over the projected period of 2020-2028. The market in North America is mainly driven by the presence of significant players in the biotechnology industry such as Vertex Pharmaceuticals Incorporated, Mylan N.V., and...

  • Cystic Fibrosis
  • Healthcare
  • North America
  • Health Expenditure

Global Carrier Screening Market to Reach $2.93 Billion by 2029 Key Questions Answered in this Report: • How the carrier screening market is expected to have an impact on the healthcare industry? • What was the total revenue generated by the global carrier screening market for autonomous in 2018...

  • Healthcare
  • Cystic Fibrosis
  • Genetic Disorder
  • Blood Disease
  • Laboratory
  • Neurological Disorder
  • World

The Europe Airway Clearance System Market would witness market growth of 4.22% CAGR during the forecast period (2019-2025). In Europe, the cost structure of home care and hospitals or psychiatric facilities differs widely due to the quality of services provided by respiratory care providers or suppliers, which include certain types...

  • Respiratory Disease
  • Cystic Fibrosis
  • Home Healthcare
  • Europe
  • United Kingdom

The ongoing clinical trial research report- “2019 Cystic Fibrosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Cystic Fibrosis trials across the world. The report presents top level analysis of global Cystic Fibrosis clinical trials across countries, companies and universities. It is designed to provide clear...

  • Cystic Fibrosis
  • Clinical Trial
  • World
  • APAC

This study covers the world outlook for cystic fibrosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Cystic Fibrosis
  • World
  • Gross Domestic Product
  • Disposable Income

Trikafta Patent, Sales & Clinical Trials Insight 2028 Report Analysis & Data Highlights: • Trikafta Patent Insight • Trikafta Dosage & Price • Trikafta Sales Forecast 2028: > USD 5 Billion • Trikafta Chemistry & Pharmacokinetic Properties • Trikafta Ongoing Clinical Trials: > 15 Clinical Studies • Role in Cystic Fibrosis...

  • Cystic Fibrosis
  • World
  • Europe
  • United States
  • Drug Approval

This study covers the world outlook for cystic fibrosis (CF) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cystic Fibrosis
  • World
  • Gross Domestic Product
  • Disposable Income